LZB (Home Furnishings) Stock Valuation & Fair Value Quality business with a solid forward outlook
LZB (Home Furnishings) trades at a blended P/E of 13.9, about 23% below its historical normal valuation, with a forward growth estimate of 7.0% and a PEG of 1.99. Analysts' one-year estimates have been hit 82% of the time.
The Street vs SeerForecast
Wall Street's mean price target for LZB is $46.00 across 2 analysts, 36.5% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: quality business with a solid forward outlook. When the two disagree, start your digging there.
Valuation flags
- No notable valuation flags.
Verdict history
tickerseer's rating has been quality business with a solid forward outlook since 2026-08-14.
Ratings recorded live since 2026-08-17. Earlier points apply today's valuation rules to the metrics tickerseer archived that week.
Frequently asked questions
Is LZB overvalued?
At a blended P/E of 13.9 versus its historical normal P/E of 17.9, LZB trades about 23% below its typical valuation, with a PEG of 1.99 on 7.0% forward growth. tickerseer currently rates it quality business with a solid forward outlook.
What is LZB's fair value and PEG?
LZB trades at a blended P/E of 13.9 against a historical normal P/E of 17.9, a PEG of 1.99, and a forward growth estimate of 7.0%.
Has tickerseer's rating of LZB changed?
tickerseer's rating has been quality business with a solid forward outlook since 2026-08-14.
What is the analyst price target for LZB?
The mean Wall Street price target for LZB is $46.00 across 2 analysts, 36.5% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Home Furnishings. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. Educational content, not investment advice.